Innova Partners with Attomarker to Accelerate COVID Immunity Testing
Innova Medical Group formed a strategic partnership with Attomarker to expedite immunity testing for COVID and other diseases globally.
Read MorePosted by Andy Lundin | May 9, 2022 | Company News, Covid 19 |
Innova Medical Group formed a strategic partnership with Attomarker to expedite immunity testing for COVID and other diseases globally.
Read MorePosted by Andy Lundin | May 9, 2022 | Sexually Transmitted Diseases |
Abbott has received FDA clearance for its Alinity m STI Assay, which simultaneously detects and differentiates four common STIs.
Read MorePosted by Andy Lundin | May 9, 2022 | Molecular Diagnostic Analyzers |
A 384-well option is now available for Thermo Fisher Scientific’s Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System.
Read MorePosted by Andy Lundin | May 6, 2022 | Covid 19, Rapid Assays |
A new study suggests continuous assessment and updating is likely needed in the context of variants of concern for rapid antigen COVID tests.
Read MorePosted by Chris Wolski | May 6, 2022 | Covid 19 |
Rutgers scientists have developed a lab test that can quickly and easily identify which the COVID-19 variants causing a patient’s infection.
Read More